טוען...
Review of Bone Modifying Agents in Metastatic Breast Cancer
Bone is the most common site for distant metastases in breast cancer and can cause significant morbidity and mortality. Bone modifying agents (BMAs) that include bisphosphonates (BPAs) and denosumab help in decreasing and delaying skeletal-related events (SREs) associated with metastatic breast canc...
שמור ב:
| הוצא לאור ב: | Cureus |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cureus
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7960030/ https://ncbi.nlm.nih.gov/pubmed/33738175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13332 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|